UMIN ID: UMIN000000642
Registered date:31/12/2013
Growth hormone replacement therapy for NASH patients due to adult pituitary gland hyposecretion
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Non Alcoholic steatohepatitis |
Date of first enrollment | 2006/08/01 |
Target sample size | 10 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Growth hormone |
Outcome(s)
Primary Outcome | liver histology |
---|---|
Secondary Outcome | transaminase CT value insulin resistance |
Key inclusion & exclusion criteria
Age minimum | 18years-old |
---|---|
Age maximum | 60years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Diabetes Mellitus Complication of malignancy During pregnancy and possibility of pregnancy Participating in the other clinical trials |
Related Information
Primary Sponsor | Gunma Liver Study Group |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Gunma Liver Study Group |
Secondary ID(s) |
Contact
public contact | |
Name | Ken Sato |
Address | 3-33-15 Showa, Maebashi, Gunma, 371-8511 Japan |
Telephone | 027-220-8127 |
satoken@showa.gunma-u.ac.jp | |
Affiliation | Gunma University Graduate School of Medicine Department of Medicine and Molecular Science |
scientific contact | |
Name | Ken Sato |
Address | 3-33-15 Showa, Maebashi, Gunma, 371-8511 Japan |
Telephone | 027-220-8127 |
satoken@showa.gunma-u.ac.jp | |
Affiliation | Gunma University Graduate School of Medicine Department of Medicine and Molecular Science |